|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01246 BOILLHEALTHCARE
Nominal 
0.021 0.000 (0.000%) | 2026/03 - Final HKD(K$) | %Chg (Compare to Final) | 2025/03 HKD(K$) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | |
| Turnover | 257,541 | 234.817% | 76,920 | 285,204 | 348,271 | 1,016,162 |
| Cost of Sales | (227,001) | 170.500% | (83,919) | (273,549) | (348,161) | (907,740) |
| Gross Profit | 30,540 | -- | (6,999) | 11,655 | 110 | 108,422 |
| 2026/03 - Final HKD(K$) | %Chg (Compare to Final) | 2025/03 HKD(K$) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | (124,732) | -83.336% | (748,512) | (59,235) | (152,566) | (631,164) | |
| Change in FV & Impairment on Others | 34 | -- | (522) | (36) | 319 | (1,850) | |
| Profit / (Loss) on Disposal | -- | -- | -- | 17,755 | -- | -- | |
| Other Non-operating Items | (34,387) | 23.765% | (27,784) | (180,599) | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | (17,721) | |
| Profit / (Loss) before Taxation | (195,639) | -77.604% | (873,527) | (275,502) | (224,636) | (744,781) | |
| Taxation | (6,928) | -- | 581 | (7,625) | (1,998) | (10,954) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | (300,941) | -- | |
| Non-controlling Interests | 8,443 | -80.356% | 42,981 | 164,487 | 99,320 | 237,937 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (194,124) | -76.611% | (829,965) | (118,640) | (428,255) | (517,798) | |
| 2026/03 - Final HKD(K$) | %Chg (Compare to Final) | 2025/03 HKD(K$) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | |
| Net Finance Costs / (Income) | 33,539 | -49.354% | 66,222 | 21,730 | 43,424 | 121,631 |
| Depreciation & Amortisation | -- | -- | 2 | 796 | 949 | 22,352 |
| Directors' Emoluments | -- | -- | 224 | 1,047 | 2,183 | 1,100 |
| 2026/03 - Final | %Chg (Compare to Final) | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| Auditor's Opinion Status | Disclaimer | -- | Disclaimer | Disclaimer | Unqualified (Modified Report) | Unqualified (Modified Report) |
Market Valuation Indicators
| 2026/03 - Final | %Chg (Compare to Final) | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| EPS (cts) | -14.290 | -76.620% | -61.120 | -8.740 | -31.540 | -38.130 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.004) | 0.006 | 0.050 | (0.084) |
| NBV per share ($) | (0.873) | -- | (0.849) | (0.245) | (0.100) | (0.008) |
| Remarks: | Real time quote last updated: 02/07/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -194,124 |
| %Change | -76.611% |
| EPS / (LPS) | HKD -0.143 |
| NBV Per Share ($) | HKD -0.873 |